概括概述信息图:一个可定制的图书馆教学材料在NIH数据管理和共享政策
1katy.smith@slu.edu, Health Sciences Librarian, Medical Center Library, Saint Louis University, St. Louis, MO.
Journal of the Medical Library Association : JMLA
|August 9, 2024
概括
这个NIH数据管理和共享政策概述将复杂的要求简化为一个可访问的信息图表. 它帮助研究人员和支持人员理解和传播关键的政策信息.
科学领域:
- 卫生政策 卫生政策
- 研究管理研究管理
- 信息科学 信息科学 信息科学
背景情况:
- 国家卫生研究院 (NIH) 实施了一项新的数据管理和共享 (DMS) 政策,自2023年1月15日起生效.
- 研究人员和机构需要明确的指导来遵守政策的数据管理和共享要求.
- 现有的政策文件可能很密集,难以广泛理解.
研究的目的:
- 为NIH数据管理和共享政策创建可访问和易理解的教学材料.
- 将复杂的政府政策语言翻译成一个视觉上有吸引力的信息图形格式.
- 支持研究人员及其机构导航NIH DMS政策.
主要方法:
- 使用免费可用的图形设计工具开发信息图形.
- 将NIH官方数据管理和共享政策文本翻译成简化的语言.
- 遵守教育目的的清晰沟通和视觉设计原则.
主要成果:
- 创建了一个通用概述信息图,提供了对NIH DMS政策的基本,清晰和线性理解.
- 该信息图有效地将复杂的政策语言转化为可访问的格式.
- 该资源以创意共享许可证共享,允许适应和重复使用.
结论:
- 概括概述信息图表是传播NIH DMS政策信息的创新教育工具.
- 图书馆和机构可以利用这个资源来宣传和教导该政策.
- 该信息图促进了对NIH数据共享要求的更广泛理解和遵守.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Biostatistics: Overview
227
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
227
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Health Information Technology and Healthcare Information System
812
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
812
Nursing Clinical Information System
763
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
763
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


